Buy & Sell International Business Machines Corp (IBM) – International Business Machines Corp Price Today
Global LIMS market to reach $5.19B by 2030, driven by automation, cloud adoption, and AI integration.
The global Laboratory Information Management Systems (LIMS) market is projected to grow from $2.88 billion in 2025 to $5.19 billion by 2030, at a CAGR of 12.5%. Growth is fueled by rising demand for laboratory automation, regulatory compliance, and d...
Cate & Chloe offers 18k gold-plated crystal earrings at $16.99 in Walmart's Summer Deals Event.
Cate & Chloe is participating in Walmart's Summer Deals Event from June 22 to June 28, offering its Eden 18k White Gold Plated Crystal Stud Earrings at a discounted price of $16.99, down from $77. This sale highlights the brand's focus on affordable ...
Global protein ingredients market to hit $121.53B by 2031, driven by demand for functional and high-protein foods.
The global protein ingredients market is projected to grow from $83.14 billion in 2026 to $121.53 billion by 2031, at a CAGR of 7.9%. Growth is fueled by rising consumer demand for functional and high-protein foods, increased awareness of protein's h...
UBS Group AG surpasses 5% ownership in Bang & Olufsen shares as of June 23, 2026
UBS Group AG has increased its stake in Bang & Olufsen A/S to 5.07% of the total share capital and voting rights as of June 23, 2026, holding 7,473,135 shares. This change follows a previous holding below 5% on June 22, 2026, marking UBS as a major s...
Law firm investigates Wealthfront over possible securities law violations after stock drops.
Johnson Fistel, PLLP is investigating Wealthfront Corporation on behalf of investors who suffered losses following the company's financial disclosures and stock price decline. Wealthfront's shares dropped significantly after reporting lower net depos...
Eli Lilly shares jump 6% after EU panel backs Jaypirca for all chronic lymphocytic leukemia patients
Eli Lilly's shares rose nearly 6% following the European Medicines Agency's CHMP recommendation to approve Jaypirca (pirtobrutinib) for adults with chronic lymphocytic leukemia (CLL) across all therapy lines. This approval would allow use regardless ...
Complex small molecules reshape drug R&D, demanding integrated discovery to manufacturing solutions.
WuXi AppTec highlights how the increasing structural complexity of small molecules, such as targeted protein degraders and covalent inhibitors, is transforming drug research and development. These new molecules require advanced, integrated approaches...
Axsome starts Phase 3 trial of solriamfetol for ADHD in adolescents, aiming to improve treatment options.
Axsome Therapeutics has initiated the FOCUS-3 Phase 3 clinical trial to evaluate solriamfetol as a treatment for adolescents aged 12 to under 18 with ADHD. This randomized, double-blind, placebo-controlled study will enroll about 468 patients to asse...
Ifetroban shows promise in protecting heart function in Duchenne muscular dystrophy patients.
Cumberland Pharmaceuticals announced updated positive results from its Phase 2 FIGHT DMD trial of ifetroban, an oral therapy targeting heart disease in Duchenne muscular dystrophy (DMD) patients. The trial showed ifetroban improves heart function by ...
OpenAI's IPO delay to 2027 shifts AI market focus to established tech giants and valuation scrutiny.
OpenAI's potential delay of its IPO to 2027 highlights a critical moment for AI valuations and the market's ability to absorb new public AI companies. Despite OpenAI's high valuation of around $852 billion and a 38x sales multiple, concerns about cas...